| Financial Year |
March 31 2023 |
| Monetary Funds |
3,468,650,912.46 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
248,532,996.35 |
| Advances to Suppliers |
181,754,365.02 |
| Other Receivables |
32,507,060.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,943,340,663.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
94,624,296.34 |
| Total Current Assets |
8,140,439,118.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
550,593,347.64 |
| Investment Properties |
-- |
| Fixed Assetes |
23,943,186,609.69 |
| Under-construction Projects |
691,626,874.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,103,203,705.70 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
63,721,029.15 |
| Deferred Income Tax Assets |
425,449,184.67 |
| Other Non-Current Assets |
174,898,669.99 |
| Sub-Total of Non-Current Assets |
30,455,294,380.54 |
| Total Assets |
38,595,733,499.15 |
| Short-Term Loans |
470,200,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,680,000,000.00 |
| Accounts Payable |
2,470,384,883.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
286,721,644.44 |
| Taxes Payable |
288,245,635.49 |
| Interest Payable |
4,457,873.03 |
| Dividend Payable |
85,584,658.00 |
| Other payables |
836,098,284.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,702,795,646.11 |
| Other Current Liabilities |
31,021,847.89 |
| Sub-Total of Current Liabilities |
8,004,097,540.43 |
| Long-term Loans |
3,988,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
990,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
134,324,284.02 |
| Deferred Income Tax Liabilities |
25,886,007.78 |
| Other Non-Current Liabilities |
8,000,000.00 |
| Sub-Total of Non-Current Liabilities |
4,275,991,243.82 |
| Total Liabilities |
12,280,088,784.25 |
| Paid-In Capital(Or Share Stock) |
3,467,957,405.00 |
| Capital Surplus |
10,693,211,169.86 |
| Surplus Reserve |
608,416,315.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
8,419,107,949.33 |
| Minority Stockholder's Interest |
3,078,699,538.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
23,236,945,176.53 |
| Owner's Equity（Stockholder's Equity） |
26,315,644,714.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
38,595,733,499.15 |
